Preliminary assessment of dietary exposure to 3-MCPD in the Netherlands During the production of refined vegetable oils and fats, and especially palm oil, a process contaminant called 3-MCPD is formed.
Lab tests alone not conclusive for diagnosis of Lyme disease Lyme disease can cause a variety of complaints in patients. Laboratory tests for the disease can support medical practitioners in making a diagnosis but are not necessarily conclusive.
Jacob van Klaveren appointed as guest Professor at the Technical University of Denmark On 15 March 2016, Jacob van Klaveren was appointed as guest Professor in risk-benefit analyses at the Technical University of Denmark, DTU.
Mental care still the most expensive of all In 2011, 19.6 billion euros was spent on the treatment of mental disorders. This amounted to 22% of the total expenditure on health and welfare during that year.
Risks of eHealth technology RIVM and Nictiz have made an overview of the risks that eHealth applications may entail and how these risks can be controlled.
Key organisations unite to improve benefit and risk assessments of vaccines Leading organisations have joined forces to launch a unique project that will pave the way for a pan-European framework for rapidly assessing and communicating the benefits and risks of vaccines.
Human and veterinary health sectors join forces for responsible use of antibiotics. Bacteria that are resistant to almost all antibiotics continue to spread across Europe. This was revealed by new figures from the European Centre for Disease Prevention and Control (ECDC).
In The Spotlight: Young Researchers RIVM 'Young Researchers' present their PhD research in 4 short films which were made especially to highlight and explain their scientific research.
Knowledge Centre Healthy Urban Living; for better quality of life in cities The Knowledge Centre on Healthy Urban Living starts on 12 November 2013.